Interestingly, miR-181a-mediated ABI1 deficiency is also observed in imatinib-resistant K562 cells, linking this mechanism of ABI1 regulation to CML [41]. The gene discussed is ABI1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.